A detailed history of Black Rock Inc. transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,074,056 shares of TNYA stock, worth $9.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,074,056
Previous 4,700,997 13.34%
Holding current value
$9.04 Million
Previous $24.6 Million 48.63%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$2.72 - $4.99 $1.71 Million - $3.13 Million
-626,941 Reduced 13.34%
4,074,056 $12.6 Million
Q1 2024

May 10, 2024

BUY
$2.88 - $6.8 $2.63 Million - $6.22 Million
914,173 Added 24.14%
4,700,997 $24.6 Million
Q4 2023

Feb 13, 2024

SELL
$1.73 - $3.39 $1.55 Million - $3.04 Million
-896,343 Reduced 19.14%
3,786,824 $12.3 Million
Q3 2023

Nov 13, 2023

BUY
$2.55 - $5.65 $2.67 Million - $5.92 Million
1,047,019 Added 28.79%
4,683,167 $11.9 Million
Q2 2023

Aug 11, 2023

BUY
$2.64 - $7.64 $2.25 Million - $6.5 Million
850,661 Added 30.54%
3,636,148 $21.3 Million
Q1 2023

May 12, 2023

BUY
$1.92 - $3.59 $1.01 Million - $1.88 Million
524,792 Added 23.21%
2,785,487 $7.94 Million
Q4 2022

Feb 13, 2023

SELL
$1.68 - $3.19 $303,552 - $576,388
-180,686 Reduced 7.4%
2,260,695 $4.54 Million
Q3 2022

Nov 14, 2022

SELL
$2.9 - $5.88 $62,489 - $126,702
-21,548 Reduced 0.87%
2,441,381 $7.08 Million
Q2 2022

Aug 12, 2022

BUY
$5.01 - $14.12 $170,625 - $480,884
34,057 Added 1.4%
2,462,929 $13.9 Million
Q1 2022

May 12, 2022

BUY
$9.41 - $19.3 $5.23 Million - $10.7 Million
555,928 Added 29.68%
2,428,872 $28.6 Million
Q4 2021

Feb 10, 2022

BUY
$18.41 - $29.58 $4.66 Million - $7.49 Million
253,225 Added 15.63%
1,872,944 $35.5 Million
Q3 2021

Nov 09, 2021

BUY
$15.35 - $26.66 $24.9 Million - $43.2 Million
1,619,719 New
1,619,719 $33.4 Million

Others Institutions Holding TNYA

About Tenaya Therapeutics, Inc.


  • Ticker TNYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,364,700
  • Market Cap $91.8M
  • Description
  • Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...
More about TNYA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.